12:00 AM
 | 
Feb 16, 2009
 |  BC Week In Review  |  Company News  |  Deals

AstraZeneca, Mayo Clinic, Virginia Polytechnic Institute and State University deal

The university and the clinic granted AstraZeneca exclusive, worldwide rights to develop and commercialize a portfolio of preclinical small molecule triple reuptake inhibitors (TRI) that...

Read the full 102 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >